Inhibitors of phosphoinositol 3 kinase and NFκB for the treatment of chronic obstructive pulmonary disease.
Recent Pat Inflamm Allergy Drug Discov
; 5(3): 178-83, 2011 Sep.
Article
em En
| MEDLINE
| ID: mdl-21827398
Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized mainly by pulmonary airflow limitation that is not fully reversible. New different pharmacological approaches to decrease inflammation of the airways and consequently disease progression and increase airway obstruction reversibility have been developed. In the present article, we review the new patents on phosphoinositide 3 kinase and NFκb inhibitors for future therapies.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Esteroides
/
NF-kappa B
/
Doença Pulmonar Obstrutiva Crônica
/
Imidazolinas
/
Inibidores de Fosfoinositídeo-3 Quinase
/
Anti-Inflamatórios
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Recent Pat Inflamm Allergy Drug Discov
Assunto da revista:
ALERGIA E IMUNOLOGIA
/
FARMACOLOGIA
Ano de publicação:
2011
Tipo de documento:
Article
País de afiliação:
Venezuela
País de publicação:
Emirados Árabes Unidos